Idenix Pharmaceuticals Inc
The Baupost Group buys stake in Fidelity National Financial
Fidelity National Financial Inc. (FNF) is a new position initiated by The Baupost Group last quarter. The position accounts for 1.82% of the fund’s 4Q portfolio.
The Baupost Group ups its stake in Idenix Pharmaceuticals
Idenix Pharmaceuticals (IDIX) accounted for a 6.25% position in Baupost’s fourth quarter portfolio. The hedge fund increased its stock holdings in Idenix last month.
Must-know highlights of the Baupost Group’s 1Q 2014 positions
Seth Klarman’s Baupost Group, LLC, returned $4 billion to clients at the end of last year. The fund is one of the best-performing hedge fund managers of all time, generating $21.5 billion in returns over its history.
Seth Klarman’s Baupost Group raises its stake in PBF Energy
The Baupost Group raised its stake in PBF Energy Inc. (PBF) by 1,021,466 shares to own 1,976,606 shares at the end of the fourth quarter.
Seth Klarman’s Baupost Group buys stake in Kindred Biosciences
The Baupost Group opened a new position in animal health company Kindred Biosciences Inc. (KIN) that accounts for 0.92% of the fund’s $3.5 billion portfolio.
The Baupost Group’s 4Q13 positions: An investor’s must-know guide
Seth Klarman’s Baupost Group, LLC was ranked the fourth best-performing hedge fund manager of all time for generating $21.5 billion in returns over its history.